On Oct. 8, 2020, bioMerieux and the Africa Medical Supplies Platform (AMSP), announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMerieux Pandemic Response Portfolio to African Union Member States.

A poetfolio of high-quality diagnostic solutions (molecular testing and serology testing) for COVID-19 from bioMerieux will be available at very competitive prices to each of the 55 African Union Member States.